Abstract
Little is known about the etiology of myelodysplastic syndromes (MDS). A hospital-based case–control study of 354 adult de novo MDS cases and 452 controls was conducted to investigate associations between lifestyle characteristics and MDS risk. The distribution by French–American–British (FAB) type was 67 (19%) refractory anemia (RA), 38 (11%) refractory anemia with ringed sideroblasts (RARS), 43 (12%) chronic myelomonocytic leukemia (CMML), 136 (38%) RA with excess blasts (RAEB), and 70 (20%) RAEB in transformation (RAEBT). Multivariate logistic regression analyses were performed among all MDS cases and among each FAB type and gender. For all MDS combined, family history of hematopoietic cancer (odds ratio (OR)=1.92), smoking (OR=1.65), and exposure to agricultural chemicals (OR=4.55) or solvents (OR=2.05) were associated with MDS risk. Among RA/RARS cases, smoking (OR=2.23) and agricultural chemical exposure (OR=5.68) were the only risk factors identified. For RAEB/RAEBT cases, family history of hematopoietic cancer (OR=2.10), smoking (OR=1.52), and exposure to agricultural chemicals (OR=3.79) or solvents (OR=2.71) were independent risk factors. Drinking wine reduced risk for all FAB types by almost 50% (OR=0.54). We found a joint effect between smoking and chemical exposure with the highest risk among smokers exposed to solvents/agricultural chemicals (OR=3.22). Results from this large study suggest that several factors play a role in MDS predisposition with possible joint effects. Risk profiles seem to differ by FAB type and gender.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Greenberg PL, Young NS, Gattermann N . Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2002, 136–161.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.
Aksoy M, Dincol K, Erdem S, Dincol G . Acute leukemia due to chronic exposure to benzene. Am J Med 1972; 52: 160–166.
Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Chow WH et al. Mortality among benzene-exposed workers in China. Environ Health Perspect 1996; 104 (Suppl 6): 1349–1352.
Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB et al. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect 1996; 104 (Suppl 6): 1339–1341.
Nilsson RI, Nordlinder R, Horte LG, Jarvholm B . Leukaemia, lymphoma, and multiple myeloma in seamen on tankers. Occup Environ Med 1998; 55: 517–521.
Christie D, Robinson K, Gordon I, Bisby J . A prospective study in the Australian petroleum industry. II. Incidence of cancer. Br J Ind Med 1991; 48: 511–514.
West RR, Stafford DA, Farrow A, Jacobs A . Occupational and environmental exposures and myelodysplasia: a case–control study. Leuk Res 1995; 19: 127–139.
Ido M, Nagata C, Kawakami N, Shimizu H, Yoshida Y, Nomura T et al. A case–control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 1996; 20: 727–731.
Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer J, Fenaux P . Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case–control study. Leukemia 1995; 9: 693–699.
Pasqualetti P, Festuccia V, Acitelli P, Collacciana A, Giusti A, Casale R . Tobacco smoking and risk of haematological malignancies in adults: a case–control study. Br J Haematol 1997; 97: 659–662.
Wong O, Harris F, Smith TJ . Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect 1993; 101 (Suppl 6): 63–76.
Caprino L, Togna GI . Potential health effects of gasoline and its constituents: a review of current literature (1990–1997) on toxicological data. Environ Health Perspect 1998; 106: 115–125.
Nagata C, Shimizu H, Hirashima K, Kakishita E, Fujimura K, Niho Y et al. Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 1999; 23: 57–62.
Spitz MR, Fueger JJ, Newell GR . The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med 1988; 4: 188–193.
Dosemeci M, Cocco P, Gomez M, Stewart PA, Heineman EF . Effects of three features of a job-exposure matrix on risk estimates. Epidemiology 1994; 5: 124–127.
Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L . Smoking and myelodysplastic syndromes. Epidemiology 2000; 11: 285–291.
Ciccone G, Mirabelli D, Levis A, Gavarotti P, Rege-Cambrin G, Davico L et al. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study. Cancer Genet Cytogenet 1993; 68: 135–139.
Ong CN, Lee BL, Shi CY, Ong HY, Lee HP . Elevated levels of benzene-related compounds in the urine of cigarette smokers. Int J Cancer 1994; 59: 177–180.
Pasqualetti P, Casale R, Colantonio D, Collacciani A . Occupational risk for hematological malignancies. Am J Hematol 1991; 38: 147–149.
Dalamage M, Petridou E, Cook F, Trichopoulos D . Risk factors for myelodysplastic syndromes: a case–control study in Greece. Cancer Causes Control 2002; 13: 603–608.
Chiu BC, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT et al. Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer 1999; 80: 1476–1482.
De Stefani E, Fierro L, Barrios E, Ronco A . Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case–control study in Uruguay. Leuk Res 1998; 22: 445–452.
Briggs NC, Levine RS, Bobo LD, Haliburton WP, Brann EA, Hennekens CH . Wine drinking and risk of non-Hodgkin's lymphoma among men in the United States: a population-based case–control study. Am J Epidemiol 2002; 156: 454–462.
Morton LM, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P et al. Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control 2003; 14: 687–694.
Bianchini F, Vainio H . Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev 2003; 12: 417–425.
Tsan MF, White JE, Maheshwari JG, Chikkappa G . Anti-leukemia effect of resveratrol. Leuk Lymphoma 2002; 43: 983–987.
Surh YJ, Hurh YJ, Kang E, Kong G, Lee SJ . Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 1999; 140: 1–10.
Jang M, Cai L, Udeani O, Slowing KV, Thomas CF, Beecher CW et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218–220.
Clement MV, Hirpara JL, Vhadhury SH, Pervaiz S . Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92: 996–1002.
Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N et al. Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings. Br J Haematol 1998; 103: 189–197.
Nisse C, Haguenoer JM, Granbastuen B, Preudhomme C, Fontaine B, Brillet JM et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 2001; 12: 927–935.
Goldberg H, Lusk E, Moore J, Nowell PC, Besa PC . Survey of exposure to genotoxic agents in primary myelodysplastic syndrome – correlation with chromosome patterns and data in patients without haematological disease. Cancer Res 1990; 50: 6876–6881.
Albin M, Bjork J, Welinder H, Tinnerberg H, Mauritzson N, Billstrom R et al. Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures. Scand J Work Environ Health 2003; 29: 378–387.
Aul C, Giagounidis A, Germing U . Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics. Int J Hematol 2001; 73: 405–410.
Phellan J, Kouides P, Bennet J . Myelodysplatic syndromes: historical aspects and classification. In: Bennet J (ed). The Myelodysplastic Syndromes Pathobiology and Clinical Management. New York: Marcel Dekker Inc., 2002.
Teschke K, Olshan AF, Daniels JL, De Roos AJ, Parks CG, Schulz M et al. Occupational exposure assessment in case–control studies: opportunities for improvement. Occup Environ Med 2002; 59: 575–594.
Acknowledgements
We acknowledge Mandy Chan, Priya Kapoor, Adriana Gonzalez-Crawley, and Patrick Pope for data collection. We are also grateful to Dr Mustafa Dosemeci for providing us with the Job Exposure Matrices used for assessing occupational exposure. Finally, this study would not have been possible without the cooperation of our participants. This work was supported by NCI Grants CA91340 and CA100632 and NIEHS ES07784.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strom, S., Gu, Y., Gruschkus, S. et al. Risk factors of myelodysplastic syndromes: a case–control study. Leukemia 19, 1912–1918 (2005). https://doi.org/10.1038/sj.leu.2403945
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403945
Keywords
This article is cited by
-
Myelodysplastic syndromes
Nature Reviews Disease Primers (2022)
-
The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens
BMC Cancer (2021)
-
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis
Nature Reviews Rheumatology (2021)
-
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
Cancer Causes & Control (2021)
-
Alcohol use is not a significant contributor to myelodysplastic syndromes
Cancer Causes & Control (2020)